- Global Pharma News & Resources

North America Clinical Chemistry Analyzer Market Overview, COVID-19 Impact Analysis, Technological Innovations with Economic Indicators By 2028

North America Clinical chemistry analyzer market is registering a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed to the increase in Laboratory Automation, reagent rental agreement and rapidly increasing aging population.

Clinical chemistry analyzer market is growing the increased demand for quality control for clinical chemistry analyzer testing by the pharmaceutical and medical device industries. However, the limited availability of animal-free testing reagents or recombinant reagents acts as a restraint for its growth in the market.

Get a Sample Copy of the Report to comprehend the construction of the total report (Including Full TOC, Table, and Figures):

Market Definition: North America Clinical Chemistry Analyzer Market

Clinical chemistry is an integral part of the body fluids evaluation and evaluation clinical pathology that plays a significant part for multifaceted disease diagnosis and therapy. For various diagnosis exams, clinical analyzers are used. Clinical analyzers are used in hospitals, academic bodies, company laboratories, blood banks, cancer study centers and other health organizations. The basis of photometric examination, colorimetric testing, latex agglutination, ion-selector potentiometry are developed by the clinical chemistry analyzers in order to analyze blood, urine, serum, plasma and the other body fluids.

Market Drivers

  • Rapidly aging population is an important indirect driver for growth of this market
  • Growing occurrence of lifestyle infections  is contributing to the growth of the market
  • Increase in the number of reagent rental agreements is boosting the growth of the market
  • Increase in laboratory automation market is propelling the growth of the market

Market Restraints

  • Necessity of high capital investments is hampering the growth of the market
  • High degree of consolidation to act as an entry barrier for new entrants is hindering the growth of the market
  • Stringent regulatory policies for medical devices are restricting the growth of the market

Major Market Key Competitors:

  • Beckman Coulter, Inc. (a subsidiary of Danaher)
  • Abbott
  • Siemens Healthcare GmbH (a subsidiary of Siemens Healthineers)
  • Randox Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd
  • ELITechGroup
  • Thermo Fisher Scientific Inc.
  • HORIBA, Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Ortho Clinical Diagnostics (a subsidiary of Carlyle Group L.P.)
  • Trivitron Healthcare
  • Nova Biomedical
  • Medica Corporation
  • Sysmex (a subsidiary of Sysmex Corporation)
  • BioSystems Diagnostics Pvt. Ltd.
  • AMS Alliance
  • ALCOR Scientific Inc.
  • Teco Diagnostics
  • DiaSys Diagnostic Systems GmbH
  • Sekisui Diagnostics

Get the Latest TOC Of This Report @

Segmentation: North America Clinical Chemistry Analyzer Market

By Product

  • Analyzers
    • Small analyzers
    • Medium analyzers
    • Large analyzers
    • Very large analyzers
  • Reagents
    • Calibrators
    • Controls
    • Standards
  • Other Products

By Test

  • Basic Metabolic Panels
  • Electrolyte Panels
  • Liver Panels
  • Lipid Profiles
  • Renal Profiles
  • Thyroid Function Panels
  • Specialty Chemical Tests

By End Users

  • Academic Research Centers
  • Diagnostic Laboratories
  • Hospitals
  • Other End Users

By Country

  • U.S.
  • Canada
  • Mexico

Key Developments in the Market:

  • In July 2018, Roche will launch its participation at the Clinical Lab Expo in the McCormick Place Convention Center of the 2018 American Association for Clinical Chemistry by showing how labs force changes to embedded wellness systems through the Protection Access to Medicare Act (PAMA) difficulties in optimizing office activities and clinical decision-making.
  • In March 2017, Beckman Coulter Diagnostics announces the release of the FDA and the U.S. corporate release of its latest DxC 700 AU Chemistry Analyzer. The latest system combines the sophisticated capacities of two promising Beckman Coulter items – the DxC analyzer’s easy interactive layout and the AU analyzer’s solid performance and workhorse skills – into a uniform platform intended to satisfy the requirements of mid- to high-volume clinical labs.

By Region

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Get More Information on this Research Report:

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of North America Clinical chemistry analyzer market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Key Offerings:

– Market Size and Forecast by Revenue | 2021−2028
– Market Dynamics – Leading patterns, development drivers, limitations, and venture openings
– Market Segmentation – An itemized examination by item, by types, end-client, applications, fragments, and geology
– Competitive Landscape – Top key sellers and other conspicuous vendorsInquire

About Data Bridge Market Research

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Data Bridge is adept at creating satisfied clients who rely on our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Editor Details

  • Company:
    • The Wire Times
Last Updated: 13-Aug-2021